• Issue

    Veterinary and Comparative Oncology: Volume 14, Issue 2

    i, 113-224, e1-e69
    June 2016
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Cover Image

Free Access

Cover Image, Volume 14, Issue 2

R. Finotello,  L. Ressel,  M. Arvigo,  G. Baroni,  V. Marchetti,  G. Romanelli,  R. Burrow,  D. Mignacca,  L. Blackwood, 
  • Page: i
  • First Published: 03 May 2016
Cover Image, Volume 14, Issue 2

The cover image, by Riccardo Finotello et al., is based on the Original Article Canine pancreatic islet cell tumours secreting insulin-like growth factor type 2 (IGF-II): a rare entity, DOI: 10.1111/vco.12085.

Original Articles

Full Access

Histologic and immunohistochemical characterization of thymic epithelial tumours in the dog

K. E. Burgess,  C. J. DeRegis,  F. S. Brown,  J. H. Keating, 
  • Pages: 113-121
  • First Published: 07 November 2013
Full Access

Comprehensive transcriptome profiling of squamous cell carcinoma of horn in Bos indicus

P. G. Koringa,  S. J. Jakhesara,  V. D. Bhatt,  C. P. Meshram,  A. K. Patel,  D. T. Fefar,  C. G. Joshi, 
  • Pages: 122-136
  • First Published: 06 December 2013
Full Access

Polymorphism of P53-Ets/AP1 transactivation region of MDM2 oncogene and its immunohistochemical analysis in canine tumours

A. Rezaie,  M. R. Tabandeh,  S. M. A. Noori, 
  • Pages: 137-146
  • First Published: 22 January 2014
Full Access

Neoadjuvant and adjuvant chemotherapy combined with anatomical resection of feline injection-site sarcoma: results in 21 cats

J. Bray,  G. Polton, 
  • Pages: 147-160
  • First Published: 07 February 2014
Full Access

Reaction phenotyping of vinblastine metabolism in dogs

S. Achanta,  L. K. Maxwell, 
  • Pages: 161-169
  • First Published: 07 February 2014
Full Access

Canine pancreatic islet cell tumours secreting insulin-like growth factor type 2: a rare entity

R. Finotello,  L. Ressel,  M. Arvigo,  G. Baroni,  V. Marchetti,  G. Romanelli,  R. Burrow,  D. Mignacca,  L. Blackwood, 
  • Pages: 170-180
  • First Published: 16 January 2014
Full Access

Lymphangiosarcoma in 12 dogs: a case series (1998–2013)

K. M. Curran,  C. H. C. Halsey,  D. R. Worley, 
  • Pages: 181-190
  • First Published: 26 February 2014
Full Access

Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation

E. B. Andreasen,  O. L. Nielsen,  M. Tranholm,  T. Knudsen,  A. T. Kristensen, 
  • Pages: 191-201
  • First Published: 28 March 2014
Full Access

Safety evaluation of combination CCNU and continuous toceranib phosphate (Palladia®) in tumour-bearing dogs: a phase I dose-finding study

X. Pan,  K. Tsimbas,  I. D. Kurzman,  D. M. Vail, 
  • Pages: 202-209
  • First Published: 16 April 2014
Full Access

Neurokinin-1 receptor expression and antagonism by the NK-1R antagonist maropitant in canine melanoma cell lines and primary tumour tissues

J. F. Borrego,  M. K. Huelsmeyer,  M. E. Pinkerton,  J. L. Muszynski,  S. A. K. Miller,  I. D. Kurzman,  D. M. Vail, 
  • Pages: 210-224
  • First Published: 22 April 2014

Online-only Special Issue on Osteosarcoma

Editorial

Full Access

The current state and a perspective towards the future of osteosarcoma in dogs

C. Khanna, 
  • Pages: e1-e3
  • First Published: 03 May 2016

Original Articles

Full Access

β-Catenin transcriptional activity is minimal in canine osteosarcoma and its targeted inhibition results in minimal changes to cell line behaviour

Caroline M. Piskun,  Timothy J. Stein, 
  • Pages: e4-e16
  • First Published: 21 November 2013
Full Access

The 5-lipoxygenase inhibitor tepoxalin induces oxidative damage and altered PTEN status prior to apoptosis in canine osteosarcoma cell lines

J. P. Loftus,  D. Cavatorta,  J. J. Bushey,  C. B. Levine,  C. S. Sevier,  J. J. Wakshlag, 
  • Pages: e17-e30
  • First Published: 12 May 2014
Full Access

Antagonism of serotonin receptor 1B decreases viability and promotes apoptosis in the COS canine osteosarcoma cell line

A. K. Viall,  C. P. Goodall,  B. Stang,  K. Marley,  P. E. Chappell,  S. Bracha, 
  • Pages: e31-e44
  • First Published: 10 June 2014
Full Access

Survivin inhibition via EZN-3042 in canine lymphoma and osteosarcoma

J. K. Shoeneman,  E. J. Ehrhart III,  J. B. Charles,  D. H. Thamm, 
  • Pages: e45-e57
  • First Published: 13 June 2014
Full Access

Osteosarcoma tissues and cell lines from patients with differing serum alkaline phosphatase concentrations display minimal differences in gene expression patterns

L. C. de Sá Rodrigues,  K. E. Holmes,  V. Thompson,  C. M. Piskun,  S. E. Lana,  M. A. Newton,  T. J. Stein, 
  • Pages: e58-e69
  • First Published: 03 February 2015